Emzor Pharmaceutical Industries

What Emzor Pharmaceutical Industries does

Emzor Pharmaceutical Industries Limited is a privately-held Nigerian pharmaceutical manufacturer and distributor founded in 1984 by Dr. Stella Okoli. The company operates four wholly-owned subsidiaries — Emzor Hesco (hospital equipment and turn-key projects), Zolon Healthcare (specialty biotech, cardiology, oncology, diagnostics), Frontwave Limited (API/procurement logistics), and Emzor Chemists (retail pharmacy) — and manufactures more than 120 product lines across 16+ therapeutic categories including analgesics, antimalarials, antibiotics, cardiovasculars, gastrointestinals, vitamins, and supplements. Manufacturing runs through ISO-certified, NAFDAC-approved, cGMP-compliant facilities at Ajao, Richfield, and Sagamu in Nigeria, with the Sagamu site slated to host Africa's first dedicated antimalarial Active Pharmaceutical Ingredient (API) plant (400 metric tonnes annual capacity, $23M project) following a €14 million European Investment Bank loan in October 2023, partnered with India's Mangalam Drugs and Organics.

Revenue is generated through a multi-tier distribution model: a network of 120+ distributors covering all 774 Local Government Areas of Nigeria serves retail pharmacies, hospitals, and wholesalers; company-owned Emzor Chemist outlets provide direct-to-consumer retail; and full-fledged operations in Liberia and Sierra Leone extend the model regionally. End customers span individual patients (driven by high-burden diseases such as malaria, for which Emzor markets the Lokmal pediatric dispersible and Maldox for pregnant women), retail pharmacies, hospitals (public and private), wholesalers, and professional healthcare networks (AGPMPN, ACPN, NMA, PSN).

The company's 'Wellocracy' brand platform is supported by targeted marketing channels including a weekly radio show on Brila FM (88.9), sports sponsorships (NFF/Super Eagles, footballer Asisat Oshoala), and CSR/health outreach campaigns such as World Malaria Day. The firm is privately held with no public ticker, no disclosed revenue, and one material external capital event — the EIB debt facility — on record.

Name

Emzor Pharmaceutical Industries

Legal name

Emzor Pharmaceutical Industries Limited

Website

https://emzorpharma.com

Company type

Private

Founded year

1984

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

Emzor Pharmaceutical Industries is a privately-held Nigerian pharmaceutical manufacturer founded in 1984, producing 120+ product lines across analgesics, antimalarials, antibiotics, and cardiovasculars via cGMP-certified facilities and distributing them through 120+ distributors across Nigeria, Liberia, and Sierra Leone.

Ownership category

akta.pro rank

Product category

Pharmaceutical Manufacturing

NAICS

Pharmaceutical Preparation Manufacturing (325412), Drugs and Druggists' Sundries Merchant Wholesalers (424210), Surgical Appliance and Supplies Manufacturing (339113)

SIC

Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)

akta.pro primary industry

Generic Finished Dosage Form (FDF) Manufacturing (HLAIABAH)

akta.pro secondary industries

Specialty Pharmaceutical Distributors (HLAIAJAB), Cold, Flu, Cough & Allergy Remedies (Decongestants, Antihistamines, Cough Syrups, Lozenges) (CRADAMAD)

Keywords

• Pharmaceutical manufacturing
• Generic medications
• Antimalarial drugs
• Antibiotic formulations
• Pharmaceutical distribution

Headquarters

HQ city

Oshodi

HQ country

Nigeria

HQ region

Africa

Offices11 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Infrastructure, Marketing or Sales, Technology or R&D

Revenue model

1. Pharmaceutical Manufacturing and Distribution: Emzor manufactures over 120 product lines including analgesics, antibiotics, antimalarials, cardiovascular drugs, gastrointestinals, vitamins, and supplements. Revenue is generated through direct distribution to pharmacies, hospitals, retailers, and wholesalers across West Africa via their 120+ distributor network.

Go-to-market motion3 records

Distribution channels5 records

Marketing channels6 records

Core offering

Emzor Pharmaceutical Industries manufactures and distributes over 120 pharmaceutical product lines across 16+ therapeutic categories—including analgesics, antibiotics, antimalarials, cardiovascular drugs, gastrointestinals, vitamins, and supplements—produced in its ISO and NAFDAC-certified cGMP-compliant manufacturing facilities in Nigeria and distributed through a network of 120+ distributors, with operations in Liberia and Sierra Leone. The company also operates wholly-owned subsidiaries for hospital equipment (Emzor Hesco), specialty healthcare (Zolon Healthcare), procurement/logistics (Frontwave Limited), and retail pharmacy (Emzor Chemists).

Product overview

Emzor Pharmaceutical Industries is a pan-African pharmaceutical manufacturer and distributor operating as a fully-owned Nigerian company with over 40 years of history. The company manufactures over 120 product lines across 16+ categories including analgesics (Emcap, Para 1000, Paracetamol), anti-malarials (Lokmal, Maldox, Piramal), antibiotics (Emzifix, Emcillin, Emtrim, Emmox), cardiovasculars (Torvastin, Emzovasc, Zoretic), gastrointestinals (Zolat, Emzolyte), vitamins/supplements (Em-Vit-C, Emvite), and other therapeutic areas. The product portfolio includes pediatric formulations (dispersible tablets, suspensions) and adult medications in various dosage forms. The company operates ISO and NAFDAC-approved manufacturing facilities in Ajao, Richfield, and Sagamu, with cGMP-compliant processes. Subsidiaries include Emzor Hesco (hospital equipment), Zolon Healthcare (specialty healthcare), Frontwave Limited (procurement/logistics), and Emzor Chemists (retail pharmacy). The company is expanding into Active Pharmaceutical Ingredient (API) manufacturing with a planned $23 million facility in Sagamu.

Differentiator

Problem solved

Functional benefit

Brands

• Emzor Hesco: Hospital equipment and services subsidiary providing solutions for diagnostic centers, medical equipment procurement, and turn-key hospital projects.
• Zolon Healthcare
• Frontwave Limited
• Emzor Chemists

Products and services

• Emcap 500mg Caplet Paracetamol-based analgesic caplet for fast relief from headaches, backaches, joint and muscular pain, cold/flu symptoms, sore throat, menstrual pains, and fever reduction; sold to consumers through pharmacies and retailers.
• Emprofen E 200mg/400mg Soft Gel Ibuprofen-containing NSAID soft gel for treatment of pain, fever, inflammation, rheumatoid arthritis, osteoarthritis, and primary dysmenorrhea.
• Emzor Paracetamol 500mg Tablets Paracetamol tablets for fast relief from pains, feverish conditions, teething pains, cold symptoms, headache, earache, muscular and general body aches.
• Para 1000mg Caplet Premium 1000mg paracetamol brand offering maximum relief in one double-strength caplet for pain and fever.
• Para Night Non-habit-forming paracetamol combination that prevents sleep interruptions due to pains, aches and fever, allowing smooth transition through sleep stages.
• Piroxicam NSAID medication for osteoarthritis and rheumatoid arthritis relief that stops the body's production of substances causing pain, fever, and inflammation.
• Lokmal Tablets Antimalarial indicated for treatment of malaria caused by all forms of plasmodium including multi-drug resistant strains of P. Falciparium.
• Lokmal QS Tablets Antimalarial quick-solve tablets for treatment of malaria including multi-drug resistant strains.
• Lokmal QS-Combi Combination antimalarial formulation for treatment of malaria.
• Lokmal Dispersible Child-friendly dispersible antimalarial formulation designed to improve ease of administration, dosing accuracy, and treatment adherence among young children.
• Lokmal Suspension Antimalarial oral suspension for children indicated for treatment of malaria caused by all forms of plasmodium including multi-drug resistant strains.
• Maldox Tablet Antimalarial tablet used in intermittent preventive treatment of malaria in pregnant women in their first and second trimester as part of antenatal care.
• Maldox Suspension Antimalarial suspension used in intermittent preventive treatment of malaria in children.
• Piramal TS (Piperaquine/Dihydroartemisinin) Anti-malarial brand effective in treating high-resistant malaria infection; once-daily dose available in adult and pediatric dosage forms.
• Emzifix (Cefixime) Cephalosporin antibiotic prescribed for treatment of bacterial infections including sore throats, ear infections, tonsillitis, pneumonia, bronchitis, UTIs, and COPD.
• Emcillin Antibiotic effective in treatment of respiratory tract infections, ear/nose/throat infections, bone and joint infections, gastrointestinal infections, urinary tract infections, and septicaemia.
• Emgyl (Metronidazole) Prescription antibiotic for treatment of sexually transmitted infections (Trichomoniasis), parasitic infections, anaerobic bacterial infections, and dental infections.
• Emtrim Antibiotic for respiratory tract infections, urinary tract infections, gastrointestinal infections, typhoid fever, skin infections, and septicaemia.
• Emmox Antibiotic indicated for respiratory tract infections, genito-urinary tract infections, skin infections, gastrointestinal infections, dental abscess, and septicaemia.
• Emzoclox Ampicillin/Cloxacillin combination antibiotic for respiratory tract, ear/nose/throat, bone and joint, gastrointestinal, and urinary tract infections.
• Torvastin (Atorvastatin) Statin medication for treatment of high cholesterol and cardiovascular risk reduction.
• Zoretic Diuretic medication for treatment of high blood pressure, fluid retention, hypokalemia in congestive heart failure, and kidney/liver conditions.
• Emzovasc (Amlodipine) Calcium channel blocker that lowers blood pressure by relaxing blood vessels; indicated for hypertension and angina pectoris.
• EmZipril (Lisinopril) ACE inhibitor (vasodilator) for treatment of congestive heart failure, high blood pressure, heart attack prevention, and diabetic kidney disease.
• Emprin (Aspirin) Aspirin with analgesic, anti-inflammatory and antipyretic actions; used for relief of pain and inflammatory conditions including rheumatoid arthritis.
• Zolat Anthelmintic chewable tablet for treatment of worm infections including pinworm, whipworm, roundworm, hookworm, and tapeworm.
• Emzolyte ORS Oral rehydration salts for replacement of electrolytes and fluids in patients with dehydration, particularly associated with acute diarrhoea.
• Motil Stop (Loperamide) Anti-diarrheal medication providing effective relief from diarrhea; contains Loperamide Hydrochloride for fast onset of action.
• Emzoron Blood tonic (haematinic) indicated for treatment of iron deficiency anaemia, megaloblastic anaemia, pregnancy anaemia, and B-complex vitamin deficiency.
• Em-Vit-C Vitamin C nutritional supplement for general health and prevention/treatment of scurvy.
• Emvite Multivitamin tablet containing numerous vitamins and minerals in balanced proportions for replenishing nutrients and preventing deficiencies.
• Em-B-Plex Vitamin B complex supplement for treatment of ADHD, thiamine deficiency, neurological disorders, heart problems, and migraine headache.
• Emzolyn Cough Syrup Palatable cough syrup for relief of dry cough and symptoms accompanying coughs and colds such as runny nose, catarrh, and nasal congestion.
• Chlorpheniramine Antihistamine for treatment of runny nose, sneezing, itching, and watery eyes caused by allergies, common cold, or flu.
• Emxidine Gel Chlorhexidine digluconate gel for umbilical cord care, prevention of tetanus/sepsis in newborns, and neonatal care.
• Emzor Hesco (Hospital Equipment and Services) Subsidiary providing solutions for hospital equipment and services including medical equipment, diagnostic centres, procurement consulting, and turn-key hospital projects, sold to hospitals and healthcare institutions.
• Zolon Healthcare (Specialty Healthcare) Specialty healthcare organization focused on biotechnology, cardiology, diagnostics, endocrinology, gastroenterology, gynecology, oncology, ophthalmology, and vector/disease control, serving healthcare providers and institutions.
• Frontwave Limited (Pharmaceutical Procurement and Logistics) Procurement company providing supply chain management services for pharmaceutical manufacturers including active pharmaceutical ingredients, packaging materials, and logistics.

Quantifiable outcome

• Nigeria accounts for approximately 27% of global malaria cases and nearly one in three malaria-related deaths
• +2 more outcomes

Named customers5 records

Segments5 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

Ten partnerships are on record, tiered core, supporting and minor.

• Mangalam Drugs and Organics (India)coreTechnology or IntegrationPartnership with India's Mangalam Drugs and Organics for the API manufacturing project, bringing technical expertise and pharmaceutical manufacturing knowledge from India to support the development of Africa's first anti-malarial API facility.
• APIFA (Non-profit Organization)supportingStrategic or Co-development PartnerSupport from APIFA non-profit organization for the API manufacturing initiative, providing additional expertise and credibility to the project.
• Association of General and Private Medical Practitioners of Nigeria (AGPMPN)coreChannel Partner/ Reseller/ DistributorAGPMPN is the umbrella organization for all medical and dental doctors in private practice. Emzor maintains strategic partnership for product distribution and professional collaboration.
• Association of Community Pharmacists of Nigeria (ACPN)coreChannel Partner/ Reseller/ DistributorACPN represents community pharmacy practice in Nigeria's health delivery system. Emzor partners with ACPN to strengthen distribution and professional networks.
• Nigerian Medical Association (NMA)coreChannel Partner/ Reseller/ DistributorNMA is the largest medical association in the West African sub-region with over 40,000 members. Strategic partnership for healthcare professional engagement.
• Pharmaceutical Society of Nigeria (PSN)coreChannel Partner/ Reseller/ DistributorPSN focuses on promoting pharmacy profession enhancement and disseminating pharmaceutical information. Emzor maintains partnership for professional collaboration and industry advocacy.
• Young Pharmacy Group (YPG)minorChannel Partner/ Reseller/ DistributorYouth arm of PSN with 15,000 members. Emzor collaborates with YPG for the Wellocracy Radio Show featuring weekly pharmacist guests discussing wellness products.
• Emzor Hesco Limited (Subsidiary)coreOthersSubsidiary providing solutions for Hospital Equipment and Services including medical equipment, diagnostic centres, procurement consulting, and turn-key hospital projects.
• Zolon Healthcare Limited (Subsidiary)coreOthersSpecialty healthcare organization with expertise in biotechnology, cardiology, diagnostics, endocrinology, gastroenterology, gynecology, neuropsychiatry, oncology, and preventive medicine.
• Frontwave Limited (Subsidiary)supportingOthersProcurement company providing logistics and supply chain services for pharmaceutical manufacturers including API sourcing, packaging materials, and industrial chemicals.

Scale indicators8 records

Recent moves8 records

Expansion highlights6 records

Broad incumbents

• Aurobindo Pharma: Aurobindo is a major Indian API and finished-dose generic manufacturer with strong African distribution, producing the same molecules (antimalarials, antibiotics, cardiovasculars) that anchor Emzor's portfolio.
• Cipla Limited: Cipla is one of India's largest generic pharmaceutical manufacturers with significant African presence, including antimalarials, antibiotics and respiratory products that directly overlap Emzor's portfolio categories.
• Sanofi: Sanofi is a global pharmaceutical incumbent with African operations producing generics, vaccines and consumer health products, providing broad competitive overlap with Emzor's categories such as cardiovascular, antimalarials and analgesics.
• Sun Pharmaceutical Industries: Sun Pharma is a global Indian generic manufacturer with a broad chronic and acute care portfolio that competes with Emzor's cardiovascular, antibiotic and analgesic offerings across emerging markets including Africa.

Regional players

• Hovid Berhad: Hovid is a Malaysian generic manufacturer with a meaningful African footprint in antibiotics, antimalarials and supplements, overlapping Emzor's product categories in West African distribution channels.
• Aspen Pharmacare Holdings: Aspen is Africa's largest pharmaceutical manufacturer by revenue, headquartered in South Africa with a generics and specialty portfolio across the continent; it competes with Emzor across multiple African markets and therapeutic categories.

Direct peers

• Fidson Healthcare Plc: Fidson is a Nigerian generic pharmaceutical manufacturer and distributor with a comparable multi-therapeutic portfolio (analgesics, antibiotics, antimalarials, cardiovasculars) and similar distribution reach across Nigeria, making it the closest domestic peer to Emzor.
• May & Baker Nigeria Plc: May & Baker is one of Nigeria's oldest pharmaceutical manufacturers producing generics, vaccines and consumer health products, sharing Emzor's focus on affordable essential medicines for the Nigerian and West African markets.
• Neimeth International Pharmaceuticals Plc: Neimeth is a Nigerian listed pharmaceutical manufacturer with a generic and specialty product portfolio that overlaps Emzor's therapeutic categories and is sold through similar pharmacy and hospital channels.
• GlaxoSmithKline Consumer Nigeria: GSK Nigeria manufactures and distributes OTC and prescription pharmaceuticals in Nigeria across categories where Emzor competes (analgesics, respiratory, vitamins), making it a relevant competitor in the same domestic market.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/emzornigeria
• YouTubeyoutube.com/channel/UC8-NaIgVVODiS-JDxF-B74g
• Facebookfacebook.com/emzornigeria
• LinkedInlinkedin.com/company/emzor-pharmaceutical-industries-ltd/about
• Instagraminstagram.com/emzornigeria

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Subsidiaries4 records

Funding overview

Funding rounds2 records

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Emzor Pharmaceutical Industries